Basic Information
LogicBio Therapeutics is a genomic editing company focused on developing therapeutics using its proprietary technology platform, GenerIDE, to provide durable treatments for rare diseases in patients with severe unmet medical needs. Its pipeline includes the product candidates LB-001, LB-101, LB-201, and LB-301.
LogicBio Therapeutics, Inc.
Cambridge,Massachusetts,United States of America
15~50 people
January 01, 2014
stephanie@tenbridgecommunications.com
Enterprise Profile
Industrial Sector
Technology
Concept
Application Scenarios